Synthetic BiologyNature CommunicationsPeer-reviewed
Engineered yeast cells simulating CD19+ cancers to control CAR T cell activation
Marcus Deichmann, Giovanni Schiesaro, Keerthana Ramanathan…·Michael Krogh Jensen
The paper presents a yeast-based system to simulate CD19+ cancers for controlled CAR T cell activation and evaluates antigen density effects.
8 citations